Initial 3-Weeks’ Apixaban Versus Dual-Antiplatelet Therapy (Clopidogrel and Aspirin) Followed by Clopidogrel Alone in High-Risk Patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): Study Protocol for a Randomized Controlled Trial
Crossref DOI link: https://doi.org/10.1007/s40261-014-0228-8
Published Online: 2014-09-09
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yang, Fang
Lei, Hui
Jiang, Wenrui
Jiang, Wen
Han, Junliang
Zhao, Gang
License valid from 2014-09-09